Farnesoid X receptor regulates vascular reactivity through nitric oxide mechanism

Journal of Physiology and Pharmacology

Volumn 63, Issue 4, 2012, Pages 367-372

  Zhang, R ^a   Ran, H H ^a   Zhang, Y X ^a   Liu, P ^a   Lu, C Y ^a   Xu, Q ^a   Huang, Y ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Chenodeoxycholic acid; Farnesoid X receptor; Nitric oxide; Superoxide; Vascular reactivity

Indexed keywords

CHENODEOXYCHOLIC ACID; FARNESOID X RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRITE; PHENYLEPHRINE; POTASSIUM CHLORIDE; SUPEROXIDE;

ABDOMINAL AORTA; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CAROTID ARTERY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMORAL ARTERY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OXIDATION REDUCTION STATE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; THORACIC AORTA; VASOCONSTRICTION; VASODILATATION;

ANIMALS; AORTA, ABDOMINAL; AORTA, THORACIC; CEREBRAL ARTERIES; CHENODEOXYCHOLIC ACID; FEMORAL ARTERY; MALE; NITRATES; NITRIC OXIDE; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SUPEROXIDES; VASOCONSTRICTION; VASODILATION;

EID: 84867783919     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Forman BM, Goode E, Chen J, et al. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 1995; 81: 687-693
2. Makishima M, Okamoto AY, Repa JJ, et al. Identification of a nuclear receptor for bile acids. Science 1999; 284: 1362- 1365
3. Zhang Y, Kast-Woelbern HR, Edwards PA. Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation. J Biol Chem 2003; 278: 104-110
4. Lu TT, Makishima M, Repa JJ, et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000; 6: 507-515
5. Fiorucci S, Cipriani S, Baldelli F, Mencarelli A. Bile acidactivated receptors in the treatment of dyslipidemia and related disorders. Prog Lipid Res 2010; 49: 171-185
6. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, Gonzalez FJ. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000; 102: 731-744
7. Bishop-Bailey D, Walsh DT, Warner TD. Expression and activation of the farnesoid X receptor in the vasculature. Proc Natl Acad Sci USA 2004; 101: 3668-3673
8. He F, Li J, Mu Y, et al. Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells. Circ Res 2006; 98: 192-199
9. Li YT, Swales KE, Thomas GJ, Warner TD, Bishop-Bailey D. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration. Arterioscler Thromb Vasc Biol 2007; 27: 2606-2611
10. Qin P, Tang X, Elloso MM, Harnish DC. Bile acids induce adhesion molecule expression in endothelial cells through activation of reactive oxygen species, NF-kappaB, and p38. Am J Physiol Heart Circ Physiol 2006; 291: H741-H747
11. Mencarelli A, Renga B, Distrutti E, Fiorucci S. Antiatherosclerotic effect of farnesoid X receptor. Am J Physiol Heart Circ Physiol 2009; 296: H272-H281
12. Hageman J, Herrema H, Groen AK, Kuipers F. A role of the bile salt receptor FXR in atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30: 1519-1528
13. Kida T, Murata T, Hori M, Ozaki H. Chronic stimulation of farnesoid X receptor impairs nitric oxide sensitivity of vascular smooth muscle. Am J Physiol Heart Circ Physiol 2009; 296: H195-H201.
14. Li J, Wilson A, Kuruba R, et al. FXR-mediated regulation of eNOS expression in vascular endothelial cells. Cardiovasc Res 2008; 77: 169-177
15. Zhang Y, Yin L, Anderson J, et al. Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia. J Biol Chem 2010; 285: 3035-3043
16. Miyazaki-Anzai S, Levi M, Kratzer A, Ting TC, Lewis LB, Miyazaki M. Farnesoid X receptor activation prevents the development of vascular calcification in ApoE-/- mice with chronic kidney disease. Circ Res 2010; 106: 1807-1817
17. Bishop-Bailey D. FXR as a novel therapeutic target for vascular disease. Drug News Perspect 2004; 17: 499-504
18. MacGilchrist AJ, Sumner D, Reid JL. Impaired pressor reactivity in cirrhosis: evidence for a peripheral vascular defect. Hepatology 1991; 13: 689-694
19. Ryan J, Sudhir K, Jennings G, Esler M, Dudley F. Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis. Gastroenterology 1993; 105: 1167-1172
20. Newby DE, Jalan R, Masumori S, Hayes PC, Boon NA, Webb DJ. Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems. Cardiovasc Res 1998; 38: 221-228
21. Murray BM, Paller MS. Decreased pressor reactivity to angiotensin II in cirrhotic rats. Evidence for a post-receptor defect in angiotensin action. Circ Res 1985; 57: 424-431.
22. Eloranta JJ, Kullak-Ublick GA. The role of FXR in disorders of bile acid homeostasis. Physiology (Bethesda) 2008; 23: 286-295
23. Hu T, Chouinard M, Cox AL, et al. Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase- 1 gene regulation. J Biol Chem 2006; 281: 39831-39838
24. Vignozzi L, Morelli A, Filippi S, et al. Farnesoid X receptor activation improves erectile function in animal models of metabolic syndrome and diabetes. J Sex Med 2011; 8: 57-77
25. Zhang Q, He F, Kuruba R, Gao X, et al. FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells. Cardiovasc Res 2008; 77: 560-569
26. Cacanyiova S, Kristek F, Malekova M, Ondrias K. Effects of chronic neuronal nitric oxide-synthase inhibition on arterial function and structure in spontaneously hypertensive rats. J Physiol Pharmacol 2012; 63: 23-28
27. Ljubuncic P, Said O, Ehrlich Y, et al. On the in vitro vasoactivity of bile acids. Br J Pharmacol 2000; 131: 387-398
28. Guzik TJ, Harrison DG. Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discov Today 2006; 11: 524-533.
29. Bauer V, Sotnikova R, Drabikova K. Effects of activated neutrophils on isolated rings of rat thoracic aorta. J Physiol Pharmacol 2011; 62: 513-520